Return
CLCF1–ZIC5–CNTFR feedback loop drives cisplatin resistance in cervical squamous cell carcinoma
Q
M
J
T
J
Y
F
X
DOI:10.1016/j.neo.2026.101342.png)
Abstract
En 中文
• ZIC5 is upregulated in CDDP-resistant cervical squamous cell carcinoma (CESC) and correlates with poor patient survival. • ZIC5 transcriptionally activates CNTFR, while CLCF1-CNTFR-STAT3 signaling induces ZIC5, forming a positive feedback loop that drives CDDP resistance and cancer stem cell properties. • Blocking CNTFR with a neutralizing antibody disrupts this loop and synergizes with cisplatin to suppress tumor growth in CESC PDX and organoid models.
Keywords:
Cervical squamous cell carcinoma
Cisplatin resistance
CLCF1
ZIC5
CNTFR
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.7
Papers:
2.8K
Citations:
8.0K
